Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia

BACKGROUND: In a recently published 24-week maintenance study of olanzapine long-acting injection (LAI) in schizophrenia (Kane et al., 2010), apparent dose-associated changes were noted in both efficacy and safety parameters. To help clinicians balance safety and efficacy when choosing a dose of ola...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Angela L, Sun, Bin, Karagianis, Jamie L, Watson, Susan B, McDonnell, David P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048520/
https://www.ncbi.nlm.nih.gov/pubmed/21324135
http://dx.doi.org/10.1186/1471-244X-11-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048520/
https://www.ncbi.nlm.nih.gov/pubmed/21324135
http://dx.doi.org/10.1186/1471-244X-11-28

Ejemplares similares